Old West Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-38,694
Closed -$348K 65
2020
Q3
$348K Hold
38,694
0.08% 46
2020
Q2
$477K Buy
+38,694
New +$438K 0.14% 44
2019
Q3
Sell
-64,364
Closed -$594K 67
2019
Q2
$594K Sell
64,364
-122,771
-66% -$1.48M 0.28% 52
2019
Q1
$2.93M Buy
187,135
+161,197
+621% +$2.84M 1.06% 20
2018
Q4
$399K Sell
25,938
-11,711
-31% -$240K 0.11% 61
2018
Q3
$810K Hold
37,649
0.33% 56
2018
Q2
$915K Buy
+37,649
New +$768K 0.46% 53
2014
Q2
Sell
-24,686
Closed -$1.3M 85
2014
Q1
$1.3M Sell
24,686
-6,247
-20% -$289K 0.81% 28
2013
Q4
$1.24M Buy
30,933
+1,773
+6% +$69.8K 0.75% 29
2013
Q3
$1.1M Buy
29,160
+733
+3% +$28.6K 0.52% 31
2013
Q2
$1.11M Buy
+28,427
New +$1.11M 0.55% 28

Other funds holding TEVA

Old West Investment Management's TEVA Position: Q4 2020 in Review

Old West Investment Management sold out of Teva Pharmaceuticals (TEVA) in Q4 2020, closing a stake of 38,694 shares — an estimated $348K sold.

Old West Investment Management first reported a position in TEVA in Q2 2013 and held it in 11 quarters. The position peaked at $2.93M in Q1 2019. 450 funds tracked by Wall St. Rank hold TEVA as of Q4 2020.

  • Old West Investment Management reported no remaining Teva Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Old West Investment Management sold 38,694 Teva Pharmaceuticals shares in Q4 2020, an estimated $348K.
  • Old West Investment Management first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 11 quarters.
  • Old West Investment Management's Teva Pharmaceuticals position peaked at $2.93M in Q1 2019.
  • 450 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2020.

Based on Old West Investment Management's 13F filing for Q4 2020, filed 16 Feb 2021.